| Using ctDNA to Determine Therapies for Lung Cancer (NCT04966663) | University Health Network, Toronto | 2022-03-28 |
| Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study (NCT05161585) | Fudan University | 2021-11-01 |
| Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC (NCT05167604) | Tang-Du Hospital | 2021-09-30 |
| Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) (NCT05598528) | Second Xiangya Hospital of Central South University | 2021-09-28 |
| CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer (NCT05027828) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2021-09-01 |
| Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization (NCT05390112) | University Hospital, Rouen | 2021-05-20 |
| Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer (NCT04530890) | Poitiers University Hospital | 2021-03-08 |
| An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease (NCT03770299) | Bristol-Myers Squibb | 2021-01-15 |
| Methylation Analysis of Circulating Tumor DNA in Gastric Cancer (NCT04511559) | Shanghai Zhongshan Hospital | 2020-10-01 |
| Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection (NCT04457297) | National Cancer Center Hospital East | 2020-07-08 |
| Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) (NCT04434040) | Dana-Farber Cancer Institute | 2020-07-02 |
| Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers. (NCT04456972) | Poitiers University Hospital | 2020-06-19 |
| Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients (NCT04229121) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-01-15 |
| IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (NCT03748680) | Karen-Lise Garm Spindler | 2018-10-01 |
| Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients (NCT03688035) | Zhiyong Yu | 2018-09-20 |
| Dynamic Monitoring of ctDNA Methylation to Predict Relapse in Colorectal Cancer After Radical Resection (POSTCA) (NCT03737539) | Fudan University | 2018-09-01 |
| OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - (NCT03750175) | Karen-Lise Garm Spindler | 2018-06-01 |
| Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy (NCT04276337) | Samsung Medical Center | 2018-03-01 |
| WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC (NCT03481101) | Rigshospitalet, Denmark | 2018-02-28 |
| Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer (NCT03615170) | Zhejiang Cancer Hospital | 2017-07-19 |
| Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer (NCT05427617) | Hunan Cancer Hospital | 2016-12-01 |
| Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer (NCT05079074) | Hunan Cancer Hospital | 2016-12-01 |
| CIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic Cancer (NCT04560270) | Poitiers University Hospital | 2016-04-25 |
| Concordance Between ctDNA Assay and FoundationOne (NCT02620527) | Foundation Medicine | 2014-11-01 |